Cell Signaling Technology

TAK1 (F2R2G) Rabbit Monoclonal Antibody

#84951 · $161

5
Citing papers
111
Combined citations
Supplier page Find this product

Research areas

Lung Cancer Treatments and Mutations4Epigenetics and DNA Methylation2RNA modifications and cancer2Colorectal Cancer Treatments and Studies1Cancer Genomics and Diagnostics1Pancreatic and Hepatic Oncology Research1Peptidase Inhibition and Analysis1Lung Cancer Research Studies1

Papers citing this product

1
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells
BMC Cancer·2020·68 cit.·DOI
2
HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer
Journal of Cancer·2021·37 cit.·DOI
3
CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancer
bioRxiv (Cold Spring Harbor Laboratory)·2024·3 cit.·DOI
4
Evolution and clinical impact of genetic epistasis within EGFR-mutant lung cancers
bioRxiv (Cold Spring Harbor Laboratory)·2017·2 cit.·DOI
5
Ezh2 Inhibitors Reverse Resistance to Gefitinib in Primary Egfr Wild-type Lung Cancer Cells
Research Square·2020·1 cit.·DOI

Similar products

ProductVendorPricePapers
TAK1 AntibodyRabbitCell Signaling Technology$317100
TAK1 (D94D7) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$157100
TAK1 (F2R2G) Rabbit Monoclonal Antibody — Evidence — PubIndex